|
oral cancer |
8 |
|
propofol |
8 |
|
pain |
6 |
|
acute postoperative pain |
5 |
|
artificial intelligence |
5 |
|
chronic pain |
5 |
|
circulating tumour cells |
5 |
|
machine learning |
5 |
|
oral leukoplakia |
5 |
|
oral lichenoid lesions |
5 |
|
oxidative stress |
5 |
|
acute |
4 |
|
adult population |
4 |
|
aging |
4 |
|
anaesthesia |
4 |
|
analgesia |
4 |
|
antioxidants |
4 |
|
bispectral index (bis) |
4 |
|
colorectal surgery |
4 |
|
dna damage |
4 |
|
general anaesthesia |
4 |
|
green tea |
4 |
|
intravenous: propofol |
4 |
|
neuropathic pain |
4 |
|
postoperative analgesia |
4 |
|
postoperative opioid consumption |
4 |
|
prevalence |
4 |
|
remifentanil |
4 |
|
sevoflurane |
4 |
|
surveys and questionnaires |
4 |
|
total intravenous anaesthesia (tiva) |
4 |
|
total intravenous anesthesia |
4 |
|
carcinogenicity |
3 |
|
chloral hydrate |
3 |
|
chromium |
3 |
|
cobalt |
3 |
|
dexmedetomidine |
3 |
|
genoprotection |
3 |
|
guidelines |
3 |
|
haemoglobin |
3 |
|
hip fracture repair |
3 |
|
hong kong |
3 |
|
hong kong population study |
3 |
|
hydrogen peroxide |
3 |
|
intranasal |
3 |
|
metastasis prediction |
3 |
|
nomogram |
3 |
|
non-cancer pain |
3 |
|
opioid |
3 |
|
opioid requirements |
3 |
|
opioid rotation |
3 |
|
opioid therapy |
3 |
|
oral oncology |
3 |
|
oral squamous cell carcinoma |
3 |
|
orthopaedic implants |
3 |
|
paediatric |
3 |
|
pain management |
3 |
|
perioperative management |
3 |
|
pharmacogenetics |
3 |
|
polymorphisms |
3 |
|
postoperative |
3 |
|
prediction |
3 |
|
redox tone |
3 |
|
secondary and tertiary prevention |
3 |
|
sedation |
3 |
|
squamous cell carcinoma |
3 |
|
surgical manipulation |
3 |
|
survival |
3 |
|
titanium |
3 |
|
tomography |
3 |
|
total hip arthroplasty |
3 |
|
acute kidney injury |
2 |
|
antioxidant |
2 |
|
are |
2 |
|
biomarkers |
2 |
|
bm |
2 |
|
bone metastasis |
2 |
|
cancer prediction |
2 |
|
cancer risk awareness |
2 |
|
cancer screening |
2 |
|
clinician on call |
2 |
|
ctcs |
2 |
|
diabetes |
2 |
|
diagnosis |
2 |
|
disease mapping |
2 |
|
dna damage and repair |
2 |
|
dna methylation |
2 |
|
epigenomics |
2 |
|
heme oxygenase-1 |
2 |
|
ho-1 |
2 |
|
hogg1 |
2 |
|
multiple tumours |
2 |
|
network meta-analysis |
2 |
|
non-drinkers |
2 |
|
non-smokers |
2 |
|
nsnd |
2 |
|
oral cavity cancer |
2 |
|
oral mucosa |
2 |
|
oral potentially malignant disorders |
2 |
|
population studies |
2 |
|
prevention |
2 |
|
pro-oxidant |
2 |
|
risk profiling |
2 |
|
sleep deprivation |
2 |
|
systematic review |
2 |
|
target-controlled infusion |
2 |
|
titration |
2 |
|
vitamin c |
2 |
|
aboriginal and torres strait islander |
1 |
|
airway audit |
1 |
|
airway complications |
1 |
|
airway incidents |
1 |
|
airway management |
1 |
|
alpha-tocopherol |
1 |
|
anaesthesia incidents |
1 |
|
anaesthesia spinal |
1 |
|
anaesthesia: spinal |
1 |
|
anaesthetists |
1 |
|
antioxidant response element |
1 |
|
antioxidant: pro-oxidant |
1 |
|
antrum |
1 |
|
ascorbic acid |
1 |
|
bioavailability |
1 |
|
biotransformation |
1 |
|
buccal cells |
1 |
|
caesarean deliver |
1 |
|
cardiac arrest |
1 |
|
cardiac surgery |
1 |
|
catechins |
1 |
|
colonic metabolites |
1 |
|
comet assay |
1 |
|
complications |
1 |
|
connectors spinal |
1 |
|
cumulative survival |
1 |
|
diabetic complications |
1 |
|
diet |
1 |
|
dna |
1 |
|
drug management |
1 |
|
egcg |
1 |
|
end-stage renal failure |
1 |
|
epigallocatechin gallate |
1 |
|
flavan-3-ol |
1 |
|
flavanols |
1 |
|
food |
1 |
|
frap |
1 |
|
frap assay |
1 |
|
free radicals |
1 |
|
ganoderma lucidum |
1 |
|
gastric emptying |
1 |
|
gastric ultrasound |
1 |
|
glucose variability |
1 |
|
glycaemic control |
1 |
|
glycemic control |
1 |
|
gt repeats |
1 |
|
haemorrhage |
1 |
|
head and neck squamous cell carcinoma |
1 |
|
hormesis |
1 |
|
human dna |
1 |
|
hyperglycemia |
1 |
|
indigenous australians |
1 |
|
interpretability |
1 |
|
lingzhi or reishi mushroom |
1 |
|
major trauma |
1 |
|
massive transfusion |
1 |
|
medicinal mushrooms |
1 |
|
metabolism |
1 |
|
microbiome |
1 |
|
morbidity |
1 |
|
musculoskeletal disorders |
1 |
|
needles |
1 |
|
needles: connectors |
1 |
|
nrf2 |
1 |
|
occupational health: epidemiology |
1 |
|
oral analgesics |
1 |
|
oral lichen planus |
1 |
|
patient prognosis |
1 |
|
patient safety |
1 |
|
phenolic compounds |
1 |
|
phytochemical |
1 |
|
polyphenols |
1 |
|
postoperative radiotherapy |
1 |
|
prognosis |
1 |
|
radiotherapy |
1 |
|
reactive oxygen species |
1 |
|
resternotomy |
1 |
|
retinopathy |
1 |
|
risk factors |
1 |
|
safety |
1 |
|
shapley values |
1 |
|
stereoselective synthesis |
1 |
|
study design |
1 |
|
tea |
1 |
|
time interval |
1 |
|
toxicity |
1 |
|
transoesophageal echocardiography |
1 |
|
transversus abdominis plane block |
1 |
|
type 2 diabetes |
1 |
|
vegetarian |
1 |
|
vitamin e |
1 |
